Anti-tumor Effects of Idarubicin Hydrochloride in Desmoid Tumors
IDH could be a promising therapeutic agent for inhibiting DTs and CRC by targeting TOPO II.
Authors
- Yonghyo Kim
- Yun‐Song Lee (ORCID: https://orcid.org/0000-0003-1147-8993)
- Y.J. Cho
- Dong‐Woo Kang (ORCID: https://orcid.org/0000-0003-2292-1946)
- Hye Jung Shin (ORCID: https://orcid.org/0000-0001-5346-7278)
- Yeong Chan Ryu (ORCID: https://orcid.org/0000-0002-9270-5408)
- Tae Il Kim (ORCID: https://orcid.org/0000-0003-4807-890X)
Institutions
- Korea Advanced Institute of Science and Technology (KR)
- Yonsei University (KR)
- Boditech Med (South Korea) (KR)
- Korea Research Institute of Chemical Technology (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17359
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00